A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor - PubMed (original) (raw)
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
J A Trofatter et al. Cell. 1993.
Erratum in
- A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.
Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, et al. Trofatter JA, et al. Cell. 1993 Nov 19;75(4):826. doi: 10.1016/0092-8674(93)90501-g. Cell. 1993. PMID: 8242753 No abstract available.
Abstract
Neurofibromatosis 2 (NF2) is a dominantly inherited disorder characterized by the occurrence of bilateral vestibular schwannomas and other central nervous system tumors including multiple meningiomas. Genetic linkage studies and investigations of both sporadic and familial tumors suggest that NF2 is caused by inactivation of a tumor suppressor gene in chromosome 22q12. We have identified a candidate gene for the NF2 tumor suppressor that has suffered nonoverlapping deletions in DNA from two independent NF2 families and alterations in meningiomas from two unrelated NF2 patients. The candidate gene encodes a 587 amino acid protein with striking similarity to several members of a family of proteins proposed to link cytoskeletal components with proteins in the cell membrane. The NF2 gene may therefore constitute a novel class of tumor suppressor gene.
Similar articles
- [Neurofibromatosis type 2 (NF2)].
Araki N, Takeshima H, Saya H. Araki N, et al. Gan To Kagaku Ryoho. 1997 Sep;24(11):1427-31. Gan To Kagaku Ryoho. 1997. PMID: 9309136 Review. Japanese. - Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ, Lowrie DJ, Sun H, Dorsey E, Pelton PD, Bashour AM, Groden J, Ratner N, Ip W. Meng JJ, et al. J Neurosci Res. 2000 Nov 15;62(4):491-502. doi: 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D. J Neurosci Res. 2000. PMID: 11070492 - A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.
Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, et al. Trofatter JA, et al. Cell. 1993 Nov 19;75(4):826. doi: 10.1016/0092-8674(93)90501-g. Cell. 1993. PMID: 8242753 No abstract available. - The mouse homologue of the neurofibromatosis type 2 gene is highly conserved.
Claudio JO, Marineau C, Rouleau GA. Claudio JO, et al. Hum Mol Genet. 1994 Jan;3(1):185-90. doi: 10.1093/hmg/3.1.185. Hum Mol Genet. 1994. PMID: 8162023 - [Molecular biological analysis of neurofibromatosis type 2 gene].
Ichimura K, Yuasa Y. Ichimura K, et al. Nihon Rinsho. 1993 Sep;51(9):2462-6. Nihon Rinsho. 1993. PMID: 8411729 Review. Japanese.
Cited by
- Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.
Yuan R, Wang B, Wang Y, Liu P. Yuan R, et al. Oncol Ther. 2024 Jun;12(2):257-276. doi: 10.1007/s40487-024-00279-2. Epub 2024 May 17. Oncol Ther. 2024. PMID: 38760612 Free PMC article. Review. - Evolving concepts in meningioma management in the era of genomics.
Hsieh AL, Bi WL, Ramesh V, Brastianos PK, Plotkin SR. Hsieh AL, et al. Cancer. 2024 Aug 1;130(15):2586-2600. doi: 10.1002/cncr.35279. Epub 2024 May 16. Cancer. 2024. PMID: 38753473 Free PMC article. Review. - A PAK family kinase and the Hippo/Yorkie pathway modulate WNT signaling to functionally integrate body axes during regeneration.
Doddihal V, Mann FG Jr, Ross EJ, McKinney MC, Guerrero-Hernández C, Brewster CE, McKinney SA, Sánchez Alvarado A. Doddihal V, et al. Proc Natl Acad Sci U S A. 2024 May 14;121(20):e2321919121. doi: 10.1073/pnas.2321919121. Epub 2024 May 7. Proc Natl Acad Sci U S A. 2024. PMID: 38713625 Free PMC article. - Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.
Thompson HL, Grabowski J, Franklin B, Koetsier KS, Welling DB. Thompson HL, et al. Clin Trials. 2024 Feb;21(1):18-28. doi: 10.1177/17407745231217279. Epub 2024 Feb 6. Clin Trials. 2024. PMID: 38321701 Free PMC article. - Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective.
Shinya Y, Teranishi Y, Hasegawa H, Miyawaki S, Sugiyama T, Shin M, Kawashima M, Umekawa M, Katano A, Nakatomi H, Saito N. Shinya Y, et al. J Neurooncol. 2024 Jan;166(1):185-194. doi: 10.1007/s11060-023-04530-0. Epub 2023 Dec 27. J Neurooncol. 2024. PMID: 38151698
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous